Conversion of water-soluble CBD to ∆9-THC in synthetic gastric fluid—An unlikely cause of positive drug tests
Abstract Cannabidiol (CBD) has been shown to convert to ∆9-tetrahydrocannabinol (∆9-THC) in acidic environments, raising a concern of conversion when exposed to gastric fluid after consumption. Using synthetic gastric fluid (SGF), it has been demonstrated that the conversion requires surfactants, su...
Saved in:
Published in | Journal of analytical toxicology Vol. 47; no. 7; pp. 632 - 635 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
15.09.2023
|
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Cannabidiol (CBD) has been shown to convert to ∆9-tetrahydrocannabinol (∆9-THC) in acidic environments, raising a concern of conversion when exposed to gastric fluid after consumption. Using synthetic gastric fluid (SGF), it has been demonstrated that the conversion requires surfactants, such as sodium dodecyl sulfate (SDS), due to limited solubility of CBD. Recently, water-compatible nanoemulsions of CBD have been prepared as a means of fortifying beverages and water-based foods with CBD. Since these emulsions contain surfactants as part of their formulation, it is possible that these preparations might enhance the production of ∆9-THC even in the absence of added surfactants. Three THC-free CBD products, an oil, an anhydrous powder and a water-soluble formulation, were incubated for 3 h in SGF without SDS. The water-soluble CBD product produced a dispersion, while the powder and the oil did not mix with the SGF. No THC was detected with the CBD oil (<0.0006% conversion), and up to 0.063% and 0.0045% conversion to ∆9-THC was observed with the water-soluble CBD and the CBD powder, respectively. No formation of ∆8-THC was observed. In comparison, when the nano-formulated CBD was incubated in SGF with 1% SDS, 33–36% conversion to ∆9-THC was observed. Even though the rate of conversion with the water-soluble CBD was at least 100-fold higher compared to the CBD oil, it was still smaller than ∆9-THC levels reported in CBD products labeled “THC-free” or “<0.3% THC” based on the Agricultural Improvement Act of 2018 (the Farm Bill). Assuming a daily CBD dose of around 30 mg/day, it is unlikely that conversion of CBD to ∆9-THC could produce a positive urinary drug test for 11-Nor-9-carboxy-∆9-THC (15 ng/mL cut-off). |
---|---|
AbstractList | Abstract
Cannabidiol (CBD) has been shown to convert to ∆9-tetrahydrocannabinol (∆9-THC) in acidic environments, raising a concern of conversion when exposed to gastric fluid after consumption. Using synthetic gastric fluid (SGF), it has been demonstrated that the conversion requires surfactants, such as sodium dodecyl sulfate (SDS), due to limited solubility of CBD. Recently, water-compatible nanoemulsions of CBD have been prepared as a means of fortifying beverages and water-based foods with CBD. Since these emulsions contain surfactants as part of their formulation, it is possible that these preparations might enhance the production of ∆9-THC even in the absence of added surfactants. Three THC-free CBD products, an oil, an anhydrous powder and a water-soluble formulation, were incubated for 3 h in SGF without SDS. The water-soluble CBD product produced a dispersion, while the powder and the oil did not mix with the SGF. No THC was detected with the CBD oil (<0.0006% conversion), and up to 0.063% and 0.0045% conversion to ∆9-THC was observed with the water-soluble CBD and the CBD powder, respectively. No formation of ∆8-THC was observed. In comparison, when the nano-formulated CBD was incubated in SGF with 1% SDS, 33–36% conversion to ∆9-THC was observed. Even though the rate of conversion with the water-soluble CBD was at least 100-fold higher compared to the CBD oil, it was still smaller than ∆9-THC levels reported in CBD products labeled “THC-free” or “<0.3% THC” based on the Agricultural Improvement Act of 2018 (the Farm Bill). Assuming a daily CBD dose of around 30 mg/day, it is unlikely that conversion of CBD to ∆9-THC could produce a positive urinary drug test for 11-Nor-9-carboxy-∆9-THC (15 ng/mL cut-off). |
Author | Flegel, Ronald R Vikingsson, Svante Winecker, Ruth E Mullen, Lawrance Hayes, Eugene D Cone, Edward J Hart, E. Dale |
Author_xml | – sequence: 1 givenname: E. Dale surname: Hart fullname: Hart, E. Dale – sequence: 2 givenname: Lawrance orcidid: 0000-0001-9397-8582 surname: Mullen fullname: Mullen, Lawrance – sequence: 3 givenname: Svante orcidid: 0000-0001-5977-3049 surname: Vikingsson fullname: Vikingsson, Svante – sequence: 4 givenname: Edward J surname: Cone fullname: Cone, Edward J – sequence: 5 givenname: Ruth E surname: Winecker fullname: Winecker, Ruth E – sequence: 6 givenname: Eugene D surname: Hayes fullname: Hayes, Eugene D – sequence: 7 givenname: Ronald R surname: Flegel fullname: Flegel, Ronald R |
BookMark | eNotkDtOAzEYhC0EEkmg4gIukdASv_ZVwvKUItFAvXK8_wYnxg62NygdFeIAHICz5Cg5CQuhml-j0fyab4j2rbOA0Akl55SUfDyXcTxdyIYIvocGtBRpwgTh-2hAqMgSkWfkEA1DmBNCsyLjAxQrZ1fgg3YWu3bz_SYj-CQ4000N4OryCkeHt58fZfJ4V2FtN99hbeMzRK3wTIboe21Np5vt-9eFxZ01egFmjZXsAvw1Ll3QUa8AN76b4QghhiN00EoT4PhfR-jp5vqxuksmD7f31cUkUZTnPBFFmaWkv6YFACkphbLpLSUYSxuVN5SVsmhIJlmaZ436XSRUW0LOhOR5JvkIne56l969dv3n-kUHBcZIC64LNSt4wdKUMNJHz3ZR5V0IHtp66fWL9OuakvqXbd2zrf_Z8h8-EnPb |
Cites_doi | 10.1016/j.forsciint.2020.110561 10.1001/jamanetworkopen.2022.23019 10.1001/jamapsychiatry.2020.3567 10.1093/jat/bkr017 10.1089/can.2017.0009 10.3390/ph13090219 10.1007/s00414-022-02896-w 10.1159/000509550 10.1089/can.2015.0004 10.1089/can.2019.0024 10.1093/jat/bkab059 10.1016/j.yebeh.2021.108514 10.1016/j.forsciint.2020.110173 10.12688/f1000research.19931.1 |
ContentType | Journal Article |
DBID | AAYXX CITATION 7X8 |
DOI | 10.1093/jat/bkad043 |
DatabaseName | CrossRef MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1945-2403 |
EndPage | 635 |
ExternalDocumentID | 10_1093_jat_bkad043 |
GroupedDBID | --- .2P .I3 .ZR 0R~ 29J 4.4 48X 5GY 5VS 5WD A8Z AABZA AACZT AAIMJ AAJKP AAKDD AAMDB AAMVS AAOGV AAPQZ AAPXW AARHZ AASNB AAUAY AAVAP AAVLN AAYXX ABEUO ABIXL ABJNI ABKDP ABMNT ABNHQ ABNKS ABOCM ABPTD ABQLI ABWST ABXVV ABZBJ ACGFO ACGFS ACIPV ACUFI ACUTJ ACUTO ADBBV ADEYI ADFTL ADGKP ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZTZ ADZXQ AEGPL AEGXH AEJOX AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFGWE AFIYH AFOFC AFXEN AGINJ AGQXC AGSYK AHXPO AIAGR AJEEA AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT ARIXL ATGXG AXUDD AYOIW BAYMD BCRHZ BEYMZ BHONS BQDIO BSWAC BTRTY BVRKM C45 CDBKE CITATION DAKXR DILTD DU5 D~K EBD EBS EE~ EMOBN ESTFP F5P F9B FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H5~ HAR HW0 HZ~ J21 KOP KQ8 KSI KSN M49 NGC NLBLG NOMLY NOYVH NU- O9- OAWHX OBOKY OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PEELM Q1. Q5Y RHF ROX RUSNO RW1 RXO SV3 TEORI TJX TLC TN5 YAE YAYTL YKOAZ YXANX 7X8 ABSAR |
ID | FETCH-LOGICAL-c1373-489650373b8ee0911e9d896c4225dc7d129a8d06a2576dc16864cf9e724a376a3 |
ISSN | 0146-4760 |
IngestDate | Thu Jul 25 09:25:16 EDT 2024 Thu Sep 26 19:44:52 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1373-489650373b8ee0911e9d896c4225dc7d129a8d06a2576dc16864cf9e724a376a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-5977-3049 0000-0001-9397-8582 |
OpenAccessLink | https://academic.oup.com/jat/advance-article-pdf/doi/10.1093/jat/bkad043/50878693/bkad043.pdf |
PQID | 2838255020 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_2838255020 crossref_primary_10_1093_jat_bkad043 |
PublicationCentury | 2000 |
PublicationDate | 2023-09-15 20230915 |
PublicationDateYYYYMMDD | 2023-09-15 |
PublicationDate_xml | – month: 09 year: 2023 text: 2023-09-15 day: 15 |
PublicationDecade | 2020 |
PublicationTitle | Journal of analytical toxicology |
PublicationYear | 2023 |
References | Gerace (2023091515445577900_R4) 2021; 318 Miller (2023091515445577900_R6) 2022; 127 Greenwich Biosciences, Inc (2023091515445577900_R16) 2018 Kiselak (2023091515445577900_R17) 2020; 308 Spindle (2023091515445577900_R5) 2022; 5 Brenan Megan (2023091515445577900_R2) 115th Congress (2023091515445577900_R1) Crippa (2023091515445577900_R11) 2020; 5 Dahlgren (2023091515445577900_R3) 2021; 78 Lachenmeier (2023091515445577900_R10) 2019; 8 Millar (2023091515445577900_R13) 2020; 13 Nahler (2023091515445577900_R8) 2017; 2 Sholler (2023091515445577900_R12) 2022; 46 Andrews (2023091515445577900_R7) 2012; 36 Merrick (2023091515445577900_R9) 2016; 1 Franz (2023091515445577900_R14) 2023; 137 ElSohly (2023091515445577900_R15) 2020; 3 |
References_xml | – volume: 318 year: 2021 ident: 2023091515445577900_R4 article-title: Determination of cannabinoids in urine, oral fluid and hair samples after repeated intake of CBD-rich cannabis by smoking publication-title: Forensic Science International doi: 10.1016/j.forsciint.2020.110561 contributor: fullname: Gerace – volume: 5 year: 2022 ident: 2023091515445577900_R5 article-title: Cannabinoid content and label accuracy of hemp-derived topical products available online and at national retail stores publication-title: JAMA Network Open doi: 10.1001/jamanetworkopen.2022.23019 contributor: fullname: Spindle – volume: 78 start-page: 335 year: 2021 ident: 2023091515445577900_R3 article-title: Urinary tetrahydrocannabinol after 4 weeks of a full-spectrum, high-cannabidiol treatment in an open-label clinical trial publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2020.3567 contributor: fullname: Dahlgren – volume: 36 start-page: 61 year: 2012 ident: 2023091515445577900_R7 article-title: Production of identical retention times and mass spectra for {delta}9-tetrahydrocannabinol and cannabidiol following derivatization with trifluoracetic anhydride with 1,1,1,3,3,3-hexafluoroisopropanol* publication-title: Journal of Analytical Toxicology doi: 10.1093/jat/bkr017 contributor: fullname: Andrews – volume: 2 start-page: 81 year: 2017 ident: 2023091515445577900_R8 article-title: A conversion of oral cannabidiol to delta9-tetrahydrocannabinol seems not to occur in humans publication-title: Cannabis Cannabinoid Res doi: 10.1089/can.2017.0009 contributor: fullname: Nahler – volume: 13 year: 2020 ident: 2023091515445577900_R13 article-title: Towards better delivery of cannabidiol (CBD) publication-title: Pharmaceuticals (Basel) doi: 10.3390/ph13090219 contributor: fullname: Millar – volume: 137 start-page: 79 year: 2023 ident: 2023091515445577900_R14 article-title: Will tetrahydrocannabinol be formed from cannabidiol in gastric fluid? An in vivo experiment publication-title: International Journal of Legal Medicine doi: 10.1007/s00414-022-02896-w contributor: fullname: Franz – volume: 3 start-page: 1 year: 2020 ident: 2023091515445577900_R15 article-title: Analysis of cannabidiol, delta(9)-tetrahydrocannabinol, and their acids in CBD oil/hemp oil products publication-title: Med Cannabis Cannabinoids doi: 10.1159/000509550 contributor: fullname: ElSohly – ident: 2023091515445577900_R1 article-title: Public Law 115-334: Agriculture Improvement Act of 2018 contributor: fullname: 115th Congress – volume: 1 start-page: 102 year: 2016 ident: 2023091515445577900_R9 article-title: Identification of psychoactive degradants of cannabidiol in simulated gastric and physiological fluid publication-title: Cannabis Cannabinoid Res doi: 10.1089/can.2015.0004 contributor: fullname: Merrick – volume: 5 start-page: 89 year: 2020 ident: 2023091515445577900_R11 article-title: Oral cannabidiol does not convert to delta(8)-THC or delta(9)-THC in humans: a pharmacokinetic study in healthy subjects publication-title: Cannabis Cannabinoid Res doi: 10.1089/can.2019.0024 contributor: fullname: Crippa – volume: 46 start-page: 494 year: 2022 ident: 2023091515445577900_R12 article-title: Urinarypharmacokinetic profile of cannabidiol (CBD), delta9-tetrahydrocannabinol (THC) and their metabolites following oral and vaporized CBD and vaporized CBD-dominant cannabis administration publication-title: Journal of Analytical Toxicology doi: 10.1093/jat/bkab059 contributor: fullname: Sholler – ident: 2023091515445577900_R2 article-title: 14% of Americans Say They Use CBD Products contributor: fullname: Brenan Megan – volume: 127 year: 2022 ident: 2023091515445577900_R6 article-title: Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: implications for patients and practitioners publication-title: Epilepsy & Behavior : E&B doi: 10.1016/j.yebeh.2021.108514 contributor: fullname: Miller – volume: 308 year: 2020 ident: 2023091515445577900_R17 article-title: Synthetic route sourcing of illicit at home cannabidiol (CBD) isomerization to psychoactive cannabinoids using ion mobility-coupled-LC-MS/MS publication-title: Forensic Science International doi: 10.1016/j.forsciint.2020.110173 contributor: fullname: Kiselak – volume: 8 year: 2019 ident: 2023091515445577900_R10 article-title: Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination? publication-title: F1000Res doi: 10.12688/f1000research.19931.1 contributor: fullname: Lachenmeier – year: 2018 ident: 2023091515445577900_R16 article-title: EPIDIOLEX® (cannabidiol) oral solution, Instructions for Use (rev. 6/2018) contributor: fullname: Greenwich Biosciences, Inc |
SSID | ssj0016863 |
Score | 2.3957744 |
Snippet | Abstract
Cannabidiol (CBD) has been shown to convert to ∆9-tetrahydrocannabinol (∆9-THC) in acidic environments, raising a concern of conversion when exposed... |
SourceID | proquest crossref |
SourceType | Aggregation Database |
StartPage | 632 |
Title | Conversion of water-soluble CBD to ∆9-THC in synthetic gastric fluid—An unlikely cause of positive drug tests |
URI | https://search.proquest.com/docview/2838255020 |
Volume | 47 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKckFCiKdYXjLScoqym83DiY9LaVXBsgiRot4i13ZW2a0S1E32wQ9A_E5-CTOx0zZSDwuXKLUiV5n5Mv5mPDMmZG8eqACWDeHm0vPcUArmJlwql-daKR9cOZZjvfPnEzaZhh9n0WwwuN7IWmrq-b78ubWu5H-0CmOgV6yS_QfNriaFAbgH_cIVNAzXW-l4iCnjbbwLOd8V0Mali_-I1VDD9x-QV7bJDMm7hHE3nQwxunFxUwLpwz6tpwIP7ZBOvmgK5R6VTlMuinO9uHGkaEyM3-R0XWpHLZtTB2ipafy0hc4K7G5iAuN1dV3IXrh-Ikxl0AhQtlhn22Lrb1P6IK6Wm_D7XrQRfFsN9u0S1b_aLalMENYcN223tWzcwg8wycJUbu5rY2t5GOHmTrBpjE37TQu6eMOyMhsG1fZXtNX-m95YZwLeaTw_F8ozPaD6fbZPvmTj6fFxlo5m6R1y1495hG77p6_r_SeWsMBWc8KUBzDhgZ2uz1_6y3fLSdKH5IGVPj0yyHhEBrp8TO6bSCw1BWZPSLVGCa1y2kMJBZTQuqJ_fv9q8UGLkq7wQS0-aIcP2uGDtvjA2Tp8UMQHbfHxlEzHo3Q4ce0xG648DOLADRMONB3u5onWQB8PNVcwJEMw9UrGChihSJTHBPqmSqJsQplzHcMnDsuTCJ6RnRJU_5xQBuuBn0cs4aEXSga2XvLc82UuIs5zxXfJXie87IfpppKZLIggAxlnVsa75G0n2AysHW5hiVJXzUUGZDgBJxh8nBe3eOYlubdG3iuyUy8b_Ro4ZD1_06r7L7BceiA |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Conversion+of+water-soluble+CBD+to+%E2%88%869-THC+in+synthetic+gastric+fluid-An+unlikely+cause+of+positive+drug+tests&rft.jtitle=Journal+of+analytical+toxicology&rft.au=Hart%2C+E+Dale&rft.au=Mullen%2C+Lawrance&rft.au=Vikingsson%2C+Svante&rft.au=Cone%2C+Edward+J&rft.date=2023-09-15&rft.eissn=1945-2403&rft.volume=47&rft.issue=7&rft.spage=632&rft.epage=635&rft_id=info:doi/10.1093%2Fjat%2Fbkad043&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0146-4760&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0146-4760&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0146-4760&client=summon |